로딩 중…
지수 로딩 중…
DongKoo Bio & Pharma Co., Ltd.
006620· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,920-4.97%
2026-06-19
Price Chart
DongKoo Bio & Pharma Co., Ltd.-28.73%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 111.58B KRW |
| Revenue | 242.08B KRW |
| Net Income | 50.28B KRW |
| Total Assets | 339.54B KRW |
| Employees | 418 |
| Value | |
| P/E | 2.22x |
| P/S | 0.46x |
| EV/EBITDA | 24.76x |
| FCF Yield | -15.68% |
| Profitability | |
| ROA | 14.81% |
| Op. Margin | 3.60% |
| Revenue Growth | -1.04% |
| Financial Health | |
| Total Debt | 127.14B KRW |
| FCF | -17.50B KRW |
| Cash | 22.74B KRW |
| Current Ratio | 0.77x |
| Net Debt/EBITDA | 11.97x |
| Dividend | |
| Div. Yield | 2.91% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -28.73% |
| 1M Return | -13.66% |
| From 52W High | -38.65% |
| 1Y MDD | -37.60% |
| Trading | |
| Volume | 106,671 shares |
| Foreign Own. | 3.75% |
| Per Share | |
| EPS | 1,770 KRW |
| BPS | 5,476 KRW |
Company Info
Established in 1983 for the manufacturing and sale of finished pharmaceuticals, the company was listed on KOSDAQ in 2018 and holds 5 consolidated subsidiaries, including Loftyrock Investment. It operates a four-business unit system: Pharmaceuticals, focusing on manufacturing and selling professional pharmaceuticals and quasi-drugs; Finance; Medical Services; and Pharmaceutical Wholesale and Consulting. The company maintains its #1 position in dermatology prescriptions, possesses differentiated manufacturing technology, and is actively pursuing entry into the cosmeceutical market and overseas expansion.